Regulation of DNA polymerase β by the LMP1 oncoprotein of EBV through the nuclear factor-κB pathway

Cancer Research

Volumn 69, Issue 12, 2009, Pages 5177-5185

  Faumont, Nathalie ^a,b,d   Le Clorennec, Christophe ^d   Teira, Pierre ^a,b   Goormachtigh, Gauthier ^e   Coll, Jean ^e   Canitrot, Yvan ^c   Cazaux, Christophe ^c   Hoffmann, Jean Sébastien ^c   Brousset, Pierre ^a,b   Delsol, Georges ^a,b   Feuillard, Jean ^d   Meggetto, Fabienne ^a,b,f  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

^e CNRS   (France)

^f CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE BETA; HETERODIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; PROTEIN P50; TRANSCRIPTION FACTOR REL;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; HOUSEKEEPING GENE; IMMOBILIZED CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRUS CARCINOGENESIS;

ANIMALS; BASE SEQUENCE; CELL LINE, TRANSFORMED; DNA; DNA POLYMERASE BETA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; VIRAL MATRIX PROTEINS;

EID: 67449128458     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2866     Document Type: Article

References (48)

1. Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005;434:864-870 (Pubitemid 40558993)
2. Bergoglio V, Pillaire MJ, Lacroix-Triki M, et al. Deregulated DNA polymerase β induces chromosome instability and tumorigenesis. Cancer Res 2002;62:3511-3514 (Pubitemid 34651401)
3. Canitrot Y, Capp JP, Puget N, et al. DNA polymerase β overexpression stimulates the Rad51-dependent homologous recombination in mammalian cells. Nucleic Acids Res 2004;32:5104-5112 (Pubitemid 39445497)
4. Pillaire MJ, Betous R, Conti C, et al. Upregulation of error-prone DNA polymerases β and κ slows down fork progression without activating the replication checkpoint. Cell Cycle 2007;6:471-477 (Pubitemid 46393453)
5. Canitrot Y, Laurent G, Astarie-Dequeker C, Bordier C, Cazaux C, Hoffmann JS. Enhanced expression and activity of DNA polymerase β in chronic myelogenous leukemia. Anticancer Res 2006;26:523-525 (Pubitemid 43206009)
6. Tan XH, Zhao M, Pan KF, et al. Frequent mutation related with overexpression of DNA polymerase β in primary tumors and precancerous lesions of human stomach. Cancer Lett 2005;220:101-114 (Pubitemid 40312023)
7. Bhattacharyya N, Banerjee T, Patel U, Banerjee S. Impaired repair activity of a truncated DNA polymerase β protein. Life Sci 2001;69:271-280 (Pubitemid 32601913)
8. Scanlon KJ, Kashani-Sabet M, Miyachi H. Differential gene expression in human cancer cells resistant to cisplatin. Cancer Invest 1989;7:581-587 (Pubitemid 20161623)
9. An FQ, Compitello N, Horwitz E, Sramkoski M, Knudsen ES, Renne R. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J Biol Chem 2005;280:3862-3874
10. Maier S, Staffler G, Hartmann A, et al. Cellular target genes of Epstein-Barr virus nuclear antigen 2. J Virol 2006;80:9761-9771 (Pubitemid 44435650)
11. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000;343:481-492 (Pubitemid 30646489)
12. Thorley-Lawson DA, Miyashita EM, Khan G. Epstein-Barr virus and the B cell: that's all it takes. Trends Microbiol 1996;4:204-208 (Pubitemid 26162134)
13. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-768 (Pubitemid 39331148)
14. Re D, Zander T, Diehl V, Wolf J. Genetic instability in Hodgkin's lymphoma. Ann Oncol 2002;13 Suppl 1:19-22. (Pubitemid 34567396)
15. Asso-Bonnet M, Feuillard J, Ferreira V, et al. Relationship between IκBα constitutive expression, TNFα synthesis, and apoptosis in EBV-infected lymphoblastoid cells. Oncogene 1998;17:1607-1615
16. Kempkes B, Pawlita M, Zimber-Strobl U, Eissner G, Laux G, Bornkamm GW. Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J κ in a conditional fashion. Virology 1995;214:675-679 (Pubitemid 26027799)
17. Le Clorennec C, Ouk TS, Youlyouz-Marfak I, et al. Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis. J Virol 2008;82:6721-6733 (Pubitemid 351875147)
18. Faumont N, Al Saati T, Brousset P, Offer C, Delsol G, Meggetto F. Demonstration by single-cell PCR that Reed-Sternberg cells and bystander B lymphocytes are infected by different Epstein-Barr virus strains in Hodgkin's disease. J Gen Virol 2001;82:1169-1174 (Pubitemid 32454616)
19. Faumont N, Trempat P, Brousset P, Delsol G, Meggetto F. In Hodgkin's disease Reed-Sternberg cells and normal B-lymphocytes are infected by related Epstein-Barr virus strains. Virus Res 2004;101:163-173
20. Faumont N, Chanut A, Benard A, et al. Comparative analysis of oncogenic properties and nuclear factor-κB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes. Haematologica 2009;94:355-363
21. Baran-Marszak F, Feuillard J, Najjar I, et al. Differential roles of STAT1α and STAT1β in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood 2004;104:2475-2483 (Pubitemid 39331850)
22. Le Clorennec C, Youlyouz-Marfak I, Adriaenssens E, Coll J, Bornkamm GW, Feuillard J. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-{κ}B, STAT1, and p53. Blood 2006;107:2070-2078 (Pubitemid 43289391)
23. Feuillard J, Schuhmacher M, Kohanna S, et al. Inducible loss of NF-κB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. Blood 2000;95:2068-2075 (Pubitemid 30151647)
24. Adriaenssens E, Mougel A, Goormachtigh G, et al. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways. Oncogene 2004;23:2681-2693 (Pubitemid 38586322)
25. Louat T, Servant L, Rols MP, et al. Antitumor activity of 2′,3′-dideoxycytidine nucleotide analog against tumors up-regulating DNA polymerase β. Mol Pharmacol 2001;60:553-558 (Pubitemid 32781563)
26. Gabert J, Beillard E, van der Velden VH, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003;17:2318-2357
27. Dignam JD, Martin PL, Shastry BS, Roeder RG. Eukaryotic gene transcription with purified components. Methods Enzymol 1983;101:582-598
28. Feuillard J, Gouy H, Bismuth G, Lee LM, Debre P, Korner M. NF-κB activation by tumor necrosis factor α in the Jurkat T cell line is independent of protein kinase A, protein kinase C, and Ca(2+)-regulated kinases. Cytokine 1991;3:257-265
29. Bergoglio V, Canitrot Y, Hogarth L, et al. Enhanced expression and activity of DNA polymerase β in human ovarian tumor cells: impact on sensitivity towards antitumor agents. Oncogene 2001;20:6181-6187 (Pubitemid 32964430)
30. Canitrot Y, Lautier D, Laurent G, et al. Mutator phenotype of BCR-ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase β. Oncogene 1999;18:2676-2680 (Pubitemid 29237655)
31. Canitrot Y, Frechet M, Servant L, Cazaux C, Hoffmann JS. Overexpression of DNA polymerase β: a genomic instability enhancer process. FASEB J 1999;13:1107-1111
32. Chen KH, Wood T, He F, Narayan S, Wilson SH. The bovine DNA polymerase β promoter: cloning, characterization and comparison with the human core promoter. Gene 1995;164:323-327
33. Widen SG, Kedar P, Wilson SH. Human β-polymerase gene. Structure of the 5′-flanking region and active promoter. J Biol Chem 1988;263:16992-16998 (Pubitemid 18268884)
34. Yamaguchi M, Hayashi Y, Matsuoka S, Takahashi T, Matsukage A. Differential effect of p53 on the promoters of mouse DNA polymerase β gene and proliferating-cell-nuclear-antigen gene. Eur J Biochem 1994;221:227-237 (Pubitemid 24120566)
35. Bavoux C, Hoffmann JS, Cazaux C. Adaptation to DNA damage and stimulation of genetic instability: the double-edged sword mammalian DNA polymerase κ. Biochimie 2005;87:637-646 (Pubitemid 40884626)
36. Bergoglio V, Bavoux C, Verbiest V, Hoffmann JS, Cazaux C. Localisation of human DNA polymerase κ to replication foci. J Cell Sci 2002;115:4413-4418 (Pubitemid 36004403)
37. Narayan S, Wilson SH. Kinetic analysis of Sp1-mediated transcriptional activation of the human DNA polymerase β promoter. Oncogene 2000;19:4729-4735 (Pubitemid 30814880)
38. Srivastava DK, Tendler CL, Milani D, English MA, Licht JD, Wilson SH. The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme β-polymerase. Aids 2001;15:433-440 (Pubitemid 32207562)
39. Eliopoulos AG, Davies C, Blake SS, et al. The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-κB signaling downstream of TRAF2. J Virol 2002;76:4567-4579 (Pubitemid 34309592)
40. Eliopoulos AG, Dumitru CD, Wang CC, Cho J, Tsichlis PN. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J 2002;21:4831-4840
41. Roberts ML, Cooper NR. Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 1998;240:93-99 (Pubitemid 28394127)
42. Gualandi G, Giselico L, Carloni M, Palitti F, Mosesso P, Alfonsi AM. Enhancement of genetic instability in human B cells by Epstein-Barr virus latent infection. Mutagenesis 2001;16:203-208 (Pubitemid 32447751)
43. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[κ]B activity. Annu Rev Immunol 2000;18:621-663 (Pubitemid 30365393)
44. Wu HC, Lu TY, Lee JJ, et al. MDM2 expression in EBV-infected nasopharyngeal carcinoma cells. Lab Invest 2004;84:1547-1556 (Pubitemid 39600562)
45. Liljeholm S, Hughes K, Grundstrom T, Brodin P. NF-κB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells. J Gen Virol 1998;79:2117-2125 (Pubitemid 28423406)
46. Thornburg NJ, Kulwichit W, Edwards RH, Shair KH, Bendt KM, Raab-Traub N. LMP1 signaling and activation of NF-κB in LMP1 transgenic mice. Oncogene 2006;25:288-297 (Pubitemid 43083690)
47. Mann KP, Thorley-Lawson D. Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein. J Virol 1987;61:2100-2108 (Pubitemid 17088920)
48. Moorthy R, Thorley-Lawson DA. Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP. J Virol 1990;64:829-837 (Pubitemid 20032700)